Mark Bieda

7.1k total citations
22 papers, 1.3k citations indexed

About

Mark Bieda is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Mark Bieda has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Oncology. Recurrent topics in Mark Bieda's work include Neuroscience and Neuropharmacology Research (5 papers), Epigenetics and DNA Methylation (5 papers) and Photoreceptor and optogenetics research (3 papers). Mark Bieda is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Epigenetics and DNA Methylation (5 papers) and Photoreceptor and optogenetics research (3 papers). Mark Bieda collaborates with scholars based in United States, Canada and Switzerland. Mark Bieda's co-authors include Peggy Farnham, Roland Green, Xiaoqin Xu, M Bruce MacIver, Michael Singer, David R. Copenhagen, Victor X. Jin, Roxanne O. Vallero, Amber Hogart and Dag H. Yasui and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mark Bieda

22 papers receiving 1.3k citations

Peers

Countries citing papers authored by Mark Bieda

Since Specialization

Citations

This map shows the geographic impact of Mark Bieda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bieda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bieda more than expected).

Fields of papers citing papers by Mark Bieda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bieda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bieda. The network helps show where Mark Bieda may publish in the future.

Co-authorship network of co-authors of Mark Bieda

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bieda. A scholar is included among the top collaborators of Mark Bieda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bieda. Mark Bieda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HER2 testing in the MOUNTAINEER trial: Analysis of treatment response based on central HER2 assessment using IHC/ISH and NGS. 2023 ·Journal of Clinical Oncology ·John H. Strickler, Andrea Cercek, Kimmie Ng, Salvatore Siena, Thierry André, Eric Van Cutsem, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, Élena Elez, Michael Stecher, (unknown), Mark Bieda, Tanios Bekaii‐Saab	5
2	551O Impact of baseline molecular alterations on the efficacy of tucatinib (TUC) plus trastuzumab (Tras) for HER2+, RAS WT metastatic CRC (mCRC) in MOUNTAINEER 2023 ·Annals of Oncology ·John H. Strickler, Andrea Cercek, Kimmie Ng, Salvatore Siena, Thierry André, E. Van Cutsem, Christina Wu, Andrew Scott Paulson, Jerry L. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, (unknown), (unknown), Michael Stecher, Paul Cronin, Mark Bieda, Tanios Bekaii‐Saab	2
3	Abstract 1140: Enfortumab vedotin, a Nectin-4 directed ADC, demonstrates compelling tolerability and anti-tumor activity with intravesical instillation in preclinical models of non-muscle invasive bladder cancer 2022 ·Cancer Research ·(unknown), (unknown), (unknown), Anthony Lee, (unknown), Amit Garg, Christine O’Day, Esther S. Trueblood, Jennifer Wright, Mark Bieda, Charles W. Caldwell, Kelly Hensley, (unknown), Bernard A. Liu, Masashi Shimazaki, Sharsti Sandall	2
4	617 Tisotumab vedotin shows immunomodulatory activity through induction of immunogenic cell death 2020 ·SHILAP Revista de lepidopterología ·Elizabeth Gray, Kelly Hensley, (unknown), Esther S. Trueblood, John J. Gosink, (unknown), Kaleb Smith, Céline Jacquemont, Mark Bieda, Jason Gow, Jeffrey R. Harris, Lauren Brady, Ibrahima Soumaoro, Shweta Jain, Leonardo Nicacio, Shyra J. Gardai	7
5	Reusable, extensible, and modifiable R scripts and Kepler workflows for comprehensive single set ChIP-seq analysis 2016 ·BMC Bioinformatics ·(unknown), Tyler Kolisnik, Mark Bieda	1
6	Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters 2014 ·BMC Genomics ·(unknown), Mark Bieda	12
7	Mutation in Folate Metabolism Causes Epigenetic Instability and Transgenerational Effects on Development 2013 ·Cell ·Nisha Padmanabhan, (unknown), (unknown), Xuchu Wu, Anne C. Ferguson‐Smith, Ernest Fung, Mark Bieda, Floyd F. Snyder, Roy A. Gravel, James C. Cross, Erica D. Watson	183
8	Kepler for ‘Omics Bioinformatics 2012 ·Procedia Computer Science ·Mark Bieda	2
9	Workflows for microarray data processing in the Kepler environment 2012 ·BMC Bioinformatics ·(unknown), Timothy McPhillips, Bertram Ludäscher, Mark Bieda	11
10	Anesthetics Discriminate Between Tonic and Phasic γ-Aminobutyric Acid Receptors on Hippocampal CA1 Neurons 2009 ·Anesthesia & Analgesia ·Mark Bieda, Henry K. Su, M Bruce MacIver	33
11	Analysis of the Mechanisms Mediating Tumor-Specific Changes in Gene Expression in Human Liver Tumors 2008 ·Cancer Research ·(unknown), Mark Bieda, Roland Green, Peggy Farnham	36
12	Identification of Genes Directly Regulated by the Oncogene ZNF217 Using Chromatin Immunoprecipitation (ChIP)-Chip Assays 2007 ·Journal of Biological Chemistry ·Sheryl R. Krig, Victor X. Jin, Mark Bieda, Henriette O’Geen, Paul Yaswen, Roland Green, Peggy Farnham	67
13	A comprehensive ChIP–chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members 2007 ·Genome Research ·Xiaoqin Xu, Mark Bieda, Victor X. Jin, (unknown), Matthew J. Oberley, Roland Green, Peggy Farnham	171
14	Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome 2006 ·Genome Research ·Mark Bieda, Xiaoqin Xu, Michael Singer, Roland Green, Peggy Farnham	268
15	N-type and L-type calcium channels mediate glycinergic synaptic inputs to retinal ganglion cells of tiger salamanders 2004 ·Visual Neuroscience ·Mark Bieda, David R. Copenhagen	14
16	Major Role For Tonic GABA_A Conductances in Anesthetic Suppression of Intrinsic Neuronal Excitability 2004 ·Journal of Neurophysiology ·Mark Bieda, M Bruce MacIver	105
17	Slow Diffusion into Brain Slices Decreases the Apparent Potency of an Anesthetic 2002 ·Anesthesiology ·(unknown), Mark Bieda, (unknown), Bruce M. MacIver	1
18	Inhibition is not required for the production of transient spiking responses from retinal ganglion cells 2000 ·Visual Neuroscience ·Mark Bieda, David R. Copenhagen	19
19	Sodium Action Potentials Are Not Required for Light-Evoked Release of GABA or Glycine From Retinal Amacrine Cells 1999 ·Journal of Neurophysiology ·Mark Bieda, David R. Copenhagen	28
20	Quinine, intracellular pH and modulation of hemi-gap junctions in catfish horizontal cells 1996 ·Vision Research ·D. Dixon, (unknown), Mark Bieda, David R. Copenhagen	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact